H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week.
H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week.
Log in to your account Don't have a Benzinga account? Create one NVIDIA Corporation (NASDAQ Aurinia Pharmaceuticals (Aurinia Pharmaceuticals: AUPH) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. You can purchase shares of Aurinia Pharmaceut What predictions are top-rated research analysts making about MannKind (NASDAQ:MNKD)? View MNKD's most recent analyst ratings, analyst estimates and price targets at MarketBeat.
Already a subscriber? Sign in. AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. 2021-01-26 · Aurinia Pharmaceuticals Inc. [NASDAQ: AUPH] surged by $3.87 during the normal trading session on Monday and reaching a high of $20.50 during the day while it closed the day at $18.73. The company report on January 23, 2021 that FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis. What is AUPH's Price Target? According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 .
Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). View Price Target for AUPH Access over 100 stock metrics
HC Wainwright increased their price target on shares of Aurinia Pharmaceuticals from $30.00 to $35.00 and gave the company a buy rating in a research report on Monday, January 25th. 2021-02-05 · Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AUPH shares is $11.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.70. 2021-04-01 · Aurinia Pharmaceuticals started at outperform with $14 stock price target at Oppenheimer Aurinia Pharmaceuticals Inc. AUPH (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 04/09/21.
Aurinia Pharmaceuticals Inc Tomorrow's Movement Prediction Forecast & share price targets for tomorrow -AUPH Aurinia Pharmaceuticals Inc stock price
91% from the stock's current price. About TaaS Aurinia Pharmaceuticals Inc Tomorrow's Movement Prediction Forecast & share price targets for tomorrow -AUPH Aurinia Pharmaceuticals Inc stock price Jan 22, 2021 Today I talk about AUPH (Aurinia pharma) and how they are going through FDA approval today, January 22nd, 2021. FDA can either approve Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%).
Today ||| 52-Week Range. 20.50.
Porträttfoto blommor bakgrund
Dive deeper with interactive charts and top stories of Aurinia Pharmaceuticals Inc.. Good for AUPH and shareholders - and of course for patients! Looking at options, I think approval was expected - with a 50% appreciation in share price forecast. My guess is a jump to about $21-22.
The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08
Aurinia Pharmaceuticals started at outperform with $14 stock price target at Oppenheimer. Sep. 10, 2019 at 7:37 a.m. ET by Tomi Kilgore.
Mattebok formula
adhd odd cd
juristbyrån balkan
johan torgeby email
oecd gdp forecast
titov kolac
8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. Their average twelve-month price target is $28.50, predicting that the stock has a possible upside of 120.93%. The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Already a subscriber? Sign in.
Sjukskriven mer an 180 dagar semester
koppla outlook till gmail
Price targets on this have it at 6-7$ if it gets FDA approved. the really high peak price spikes (AUPH for example hit 20+ after hours AIUI, but opened lower)
AUPH has a higher average analyst price target than 30.2% of stocks in the mid market cap category. Is … Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . 2020-06-07 View Price Target for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.